Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT01972568

Public ClinicalTrials.gov record NCT01972568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)

Study identification

NCT ID
NCT01972568
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
EMD Serono
Industry
Enrollment
306 participants

Conditions and interventions

Interventions

  • Atacicept 75 milligram (mg) Drug
  • Atacicept 150 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2013
Primary completion
Mar 31, 2016
Completion
Aug 31, 2016
Last update posted
Jan 1, 2018

2013 – 2016

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
Pinnacle Research Group LLC Anniston Alabama 36207
Achieve Clinical Research, LLC Birmingham Alabama 35216
University of Alabama at Birmingham - (UAB) Birmingham Alabama 35294
Southern California Permanente Medical Group Anaheim California 92806
Wallace Rheumatic Study Center Los Angeles California 90048
East Bay Rheumatology Medical Group, Inc. San Leandro California 94578
Clinical Research of West Florida - Corporate Dunedin Florida 34698
Center for Rheumatology, Immunology & Arthritis Fort Lauderdale Florida 33309
University of Miami Miller School of Medicine Miami Florida 33136
Clinical Research of West Florida, Inc. Tampa Florida 33603
Goldpoint Clinical Research, LLC Indianapolis Indiana 46260
AA MRC LLC Ahmed Arif Medical Research Center Grand Blanc Michigan 48439
Mayo Clinic Rochester Minnesota 55905
North MS Medical Clinics, Inc. Tupelo Mississippi 38801
Washington University School of Medicine St Louis Missouri 63110
Rutgers New Jersey Medical School Newark New Jersey 07103
The Feinstein Institute for Medical Research Manhasset New York 11031
Hospital for Special Surgery New York New York 10021
Box Arthritis & Rheumatology of the Carolinas PLLC Charlotte North Carolina 28210
MetroHealth System Cleveland Ohio 44109
Ohio State University Medical Center Columbus Ohio 43210
STAT Research, Inc. Dayton Ohio 45417
Arthritis & Rheumatology Center of Oklahoma Oklahoma City Oklahoma 73103
OMRF Oklahoma City Oklahoma 73104
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Clinical Research Center of Reading LLC Wyomissing Pennsylvania 19610
Medical University of South Carolina (MUSC) Charleston South Carolina 29425
UTMB Pathology Clinical Services Galveston Texas 77555
Arthritis & Osteoporosis Clinic Waco Texas 76708
Danville Orthopedic Clinic, Inc. Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 108 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01972568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 1, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01972568 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →